메뉴 건너뛰기
American Journal of Hypertension
Volumn 22, Issue 9, 2009, Pages 954-957
Aliskiren monotherapy results in the greatest and the least blood pressure lowering in patients with high- and low-baseline PRA levels, respectively
Author keywords

[No Author keywords available]
Indexed keywords

ALISKIREN; IRBESARTAN; RAMIPRIL;
EID: 69249202278     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1038/ajh.2009.114     Document Type: Article
Times cited : (40)
References (6)
  • 1
    • 57749203164 scopus 로고    scopus 로고
    • Aliskiren fails to lower blood pressure in patients who have either low PRA levels or whose PRA falls insufficiently or reactively rises
    • Sealey JE, Laragh JH. Aliskiren fails to lower blood pressure in patients who have either low PRA levels or whose PRA falls insufficiently or reactively rises. Am J Hypertens 2009; 22:112-121.
    • (2009) Am J Hypertens , vol.22 , pp. 112-121
    • Sealey, J.E.1    Laragh, J.H.2
  • 2
    • 0347479295 scopus 로고    scopus 로고
    • Blood pressure lowering in essential hypertension with an oral renin inhibitor, aliskiren
    • Stanton A, Jensen C, Nussberger J, O'Brien E. Blood pressure lowering in essential hypertension with an oral renin inhibitor, aliskiren. Hypertension 2003; 42:1137-1143.
    • (2003) Hypertension , vol.42 , pp. 1137-1143
    • Stanton, A.1    Jensen, C.2    Nussberger, J.3    O'Brien, E.4
  • 3
    • 34547726196 scopus 로고    scopus 로고
    • Plasma renin and the antihypertensive effect of the orally active renin inhibitor aliskiren in clinical hypertension
    • Nussberger J, Gradman AH, Schmieder RE, Lins RL, Chiang Y, Prescott MF. Plasma renin and the antihypertensive effect of the orally active renin inhibitor aliskiren in clinical hypertension. Int J Clin Pract 2007; 61:1461-1468.
    • (2007) Int J Clin Pract , vol.61 , pp. 1461-1468
    • Nussberger, J.1    Gradman, A.H.2    Schmieder, R.E.3    Lins, R.L.4    Chiang, Y.5    Prescott, M.F.6
  • 4
    • 33846421005 scopus 로고    scopus 로고
    • Aliskiren reduces blood pressure and suppresses plasma renin activity in combination with a thiazide diuretic, an angiotensin-converting-enzyme inhibitor or an angiotensin receptor blocker
    • O'Brien E, Barton J, Nussberger J, Mulcahy D, Jensen C, Dicker P, Stanton A. Aliskiren reduces blood pressure and suppresses plasma renin activity in combination with a thiazide diuretic, an angiotensin-converting-enzyme inhibitor or an angiotensin receptor blocker. Hypertension 2007; 49: 276-284.
    • (2007) Hypertension , vol.49 , pp. 276-284
    • O'Brien, E.1    Barton, J.2    Nussberger, J.3    Mulcahy, D.4    Jensen, C.5    Dicker, P.6    Stanton, A.7
  • 5
    • 34447521458 scopus 로고    scopus 로고
    • Efficacy and safety of combined use of aliskiren and valsartan in patients with hypertension: A randomised, double-blind trial
    • Oparil S, Yarows SA, Patel S, Fang H, Zhang J, Satlin A. Efficacy and safety of combined use of aliskiren and valsartan in patients with hypertension: a randomised, double-blind trial. Lancet 2007; 370:221-229.
    • (2007) Lancet , vol.370 , pp. 221-229
    • Oparil, S.1    Yarows, S.A.2    Patel, S.3    Fang, H.4    Zhang, J.5    Satlin, A.6
  • 6
    • 34548166766 scopus 로고    scopus 로고
    • Renin: Friend or foe?
    • Brown MJ. Renin: friend or foe? Heart 2007; 93:1026-1033.
    • (2007) Heart , vol.93 , pp. 1026-1033
    • Brown, M.J.1

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.